Breakdown | |||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|
Income Statement | Total Revenue | ||
2.64B | 2.90B | 2.76B | 2.16B | Gross Profit |
220.67M | 273.44M | 180.05M | 186.05M | EBIT |
86.78M | -77.56M | 81.71M | 99.53M | EBITDA |
241.46M | 85.32M | 67.50M | 229.05M | Net Income Common Stockholders |
-6.72M | -186.18M | -168.15M | 40.51M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||
49.02M | 33.41M | 63.97M | 114.71M | Total Assets |
2.07B | 2.19B | 2.56B | 2.57B | Total Debt |
1.01B | 1.31B | 1.33B | 1.36B | Net Debt |
959.64M | 1.28B | 1.27B | 1.25B | Total Liabilities |
1.51B | 1.86B | 2.01B | 1.89B | Stockholders Equity |
555.55M | 225.99M | 386.75M | 479.61M |
Cash Flow | Free Cash Flow | ||
58.90M | 60.81M | -34.96M | -937.00K | Operating Cash Flow |
158.23M | 167.47M | 94.63M | 109.48M | Investing Cash Flow |
-89.38M | -94.85M | -156.71M | -916.58M | Financing Cash Flow |
-52.62M | -103.45M | 12.20M | 883.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $1.63B | 16.05 | 7.36% | 4.78% | 3.88% | 11.80% | |
68 Neutral | $219.53M | 16.54 | 11.60% | 3.88% | 9.74% | -1.29% | |
67 Neutral | $2.82B | 22.40 | 9.04% | 2.09% | 20.41% | 13.64% | |
63 Neutral | $1.23B | 13.08 | 14.42% | 6.85% | 4.02% | -14.66% | |
57 Neutral | $4.81B | 19.87 | -17.81% | 5.21% | 13.60% | -27.95% | |
54 Neutral | $769.08M | 11.07 | -28.47% | 15.32% | -15.03% | -201.87% | |
50 Neutral | $1.65B | 1,770.48 | 0.11% | ― | ― | ― |
On May 19, 2025, Centuri Holdings, Inc. entered into a Registration Rights Letter Agreement with Icahn Investors, granting them certain resale registration rights related to a Concurrent Private Placement. The company agreed to register the resale of shares sold to Icahn Investors within 181 days of the placement’s completion. Additionally, on May 20, 2025, Centuri Holdings entered into an Underwriting Agreement with J.P. Morgan Securities LLC and other underwriters for an offering. The agreement includes a 45-day lock-up period for selling or transferring Centuri Common Stock, with customary representations and indemnification obligations.
The most recent analyst rating on (CTRI) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Centuri Holdings, Inc. stock, see the CTRI Stock Forecast page.